---
figid: PMC10480466__41419_2023_6092_Fig7_HTML
figtitle: Lenvatinib inhibition of EMT in ICC cells
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10480466
filename: PMC10480466__41419_2023_6092_Fig7_HTML.jpg
figlink: /pmc/articles/PMC10480466/figure/F7
number: F7
caption: Lenvatinib enhanced AZGP1 activity through H3K27Ac modification and inhibited
  the downstream TGF-β1/Smad3 signaling pathway.
papertitle: AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma
  epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway
reftext: Liming Deng, et al. Cell Death Dis. 2023 Sep;14(9):590.
year: '2023'
doi: 10.1038/s41419-023-06092-5
journal_title: Cell Death & Disease
journal_nlm_ta: Cell Death Dis
publisher_name: Nature Publishing Group UK
keywords: Oncogenes | Oncogenes
automl_pathway: 0.9597555
figid_alias: PMC10480466__F7
figtype: Figure
redirect_from: /figures/PMC10480466__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10480466__41419_2023_6092_Fig7_HTML.html
  '@type': Dataset
  description: Lenvatinib enhanced AZGP1 activity through H3K27Ac modification and
    inhibited the downstream TGF-β1/Smad3 signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AZGP1
  - TGFB1
  - SMAD3
  - CDH1
  - FZR1
  - CDH2
  - Lenvatinib
---
